Treatment Response to Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy: 96-Week Results From the EXPLORER Cohort of the MAVA-Long-Term Extension Cardiac Magnetic Resonance Imaging Substudy

By afschroeder • September 23, 2025

Saberi S, Kramer CM, Oręziak A, Masri A, Barriales-Villa R, Abraham TP, Lakdawala NK, Wang A, Choudhury L, Rader F, Havakuk O, Stendahl JC, Cardim N, Seidler T, Sherrid M, Hegde SM, Kwong RY, Jerosch-Herold M, Balaratnam G, Kurio G, Fox S, Olivotto I, Owens A. Treatment Response to Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy: 96-Week Results From the EXPLORER Cohort of the MAVA-Long-Term Extension Cardiac Magnetic Resonance Imaging Substudy. Circulation. 2025 Sep 23;152(12):905-908. doi: 10.1161/CIRCULATIONAHA.124.071188. Epub 2025 Sep 22. PMID: 40982583.

Tags: Cardiology/Epi, cardiomyopathies, cardiomyopathy, Cedars Sinai DoM, hypertrophic, Magnetic resonance imaging, Publications

Characteristics and Outcomes of Over One Million Veterans with Heart Failure Phenotyped Using Artificial Intelligence Approaches: The National DCVA-HF Registry

Zhang S, Raman VK, Shao Y, Patel S, Cheng Y, Workman TE, Sheriff HM, Fonarow GC, Lam PH, Heidenreich PA, Morgan CJ, Moore HJ, Vargas[...]

Cardiology Provider Knowledge and Attitudes Toward Cardiac Gene Therapy: A Multi-Institutional National Survey

Silver E, Punt M, Wang J, Brann A, Khedraki R, Kumar S, Duran A, Greenberg B, Hong KN, Bui QM. Cardiology Provider Knowledge and Attitudes[...]

Pericoronary adipose tissue as a biomarker of coronary atherosclerosis and cardiovascular risk in rheumatoid arthritis

Karpouzas GA, Cosedis Enevoldsen F, Rezaeian P, Masic D, Budoff MJ, Hauge EM, Ormseth SR. Pericoronary adipose tissue as a biomarker of coronary atherosclerosis and[...]